Bone and Mineral Disorders Journal Articles

• Bone Health Optimization (BHO) in Spine Surgery How important is bone health optimization in spine surgery patients? Find out what there is to know.
  Spine, May 30, 2023
• Insulin and BMI Lower Serum Soluble Leptin Receptor Levels A new study found that a higher fasting insulin and higher BMI could be associated with lower serum soluble leptin receptor levels. What are the implications?
  Journal of Clinical Endocrinology & Metabolism, May 30, 2023
• Supporting Hypercalcemia of Malignancy Treatment Guidelines Does the available evidence support clinical recommendations for the treatment of adults with hypercalcemia of malignancy?
  Journal of Clinical Endocrinology & Metabolism, April 04, 2023
• Stability of Vitamin D Status and Its Association With BMD Might variations in vitamin D status affect bone mineral density over time? A new study examines the potential impacts.
  Journal of the Endocrine Society, February 21, 2023
• EpiVida -- A Study of Vitamin D Status in Adults in Brazil An epidemiological analysis of vitamin D status among individuals in Brazil provides insight into the prevalence of vitamin D deficiency in this group.
  Journal of the Endocrine Society, January 31, 2023
• Pyoderma Gangrenosum Associated With IgG Multiple Myeloma In this report, a patient was diagnosed with underlying IgG multiple myeloma after presenting with pyoderma gangrenosum lesions. How was it ultimately diagnosed and managed?
  Wounds, January 11, 2023
• Lack of Bone Mineral Density Testing in Hypogonadal Men Despite the known risk for osteoporosis, only a small percentage of hypogonadal men undergo bone mineral density testing. What accounts for the oversight?
  Journal of the Endocrine Society, January 10, 2023
• Muscle Adiposity in Children With XLH Rickets This study found a higher percentage of intramuscular adipose tissue among children with X-linked hypophosphatemic rickets than in typically developing children. What are the implications?
  Journal of the Endocrine Society, December 27, 2022
• Vitamin D Supplementation and Risk of Keratinocyte Cancer Might vitamin D supplementation reduce the incidence of keratinocyte cancers or other actinic lesions?
  The British Journal of Dermatology, November 28, 2022
• Obesity and COVID-19: Insights From Adipose Tissue Obesity has been established as a risk factor for severe COVID-19. Is adipose tissue the key to unlocking the mechanism behind this association?
  Journal of Clinical Endocrinology & Metabolism, November 23, 2022
• Secondary Hyperparathyroidism Treatment and Dementia Risk Are end-stage renal disease patients who are receiving therapy for secondary hyperparathyroidism at an increased risk for developing dementia?
  Nephrology Dialysis Transplantation, November 14, 2022
• Serology and Comorbidities in Fracture Nonunion Patients How common are serologic abnormalities and comorbid conditions among patients with nonunion fracture?
  Journal of the American Academy of Orthopaedic Surgeons, October 28, 2022
• The Relationship of Headache As a Symptom to COVID-19 Survival How does headache as a symptom of COVID-19 impact mortality rates? This analysis indicates that COVID-19 patients who experience headache are twice as likely to survive as those without headache.
  Headache, October 26, 2022
• Effects of Kisspeptin on Bone Metabolism in Healthy Men The beneficial effects of kisspeptin on bone metabolism could lead to a potentially exciting new role for this hormone in the treatment of osteoporosis.
  Journal of Clinical Endocrinology & Metabolism, October 26, 2022
• A Practical Guide to Genetic Testing in Endocrinology What role do genetics have in the field of endocrinology? This article offers a practical guide.
  Clinical Endocrinology, October 13, 2022
• Prognostic and Therapeutic Role of Vitamin D in COVID-19 Learn more about the association between vitamin D levels and COVID-19 and its potential role as a therapeutic agent.
  Journal of Clinical Endocrinology & Metabolism, October 12, 2022
• Osteonecrosis of the Jaw and Antiresorptive Agents Antiresorptive agents are commonly used to prevent bone loss and fractures, but prolonged use could potentially lead to osteonecrosis of the jaw. Which patients are most at risk?
  Journal of Clinical Endocrinology & Metabolism, October 05, 2022
• Reduced Fractures After Primary Hyperparathyroidism Surgery Primary hyperparathyroidism is associated with a greater risk for fractures, but undergoing surgery may help reduce this risk.
  Clinical Endocrinology, September 29, 2022
• Vitamin D Supplementation and Fractures in Adults Contradicting results from various systematic reviews/meta-analyses has led to variability in vitamin D guidelines for fracture prevention. What accounts for the discrepancies?
  Journal of Clinical Endocrinology & Metabolism, September 28, 2022
• Cabozantinib Combined With Atezolizumab for Advanced RCC This novel therapeutic combination shows encouraging results in patients with advanced renal cell carcinoma.
  Journal of Clinical Oncology, September 01, 2022